Vergnenegre A, Monnet I, Ricordel C, Bizieux A, et al. Safety and efficacy of second-line metronomic oral vinorelbine-atezolizumab combination in stage IV non-small-cell lung cancer: An open-label phase II trial (VinMetAtezo). Lung Cancer 2023;178:191-197.
PMID: 36868180